Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · IEX Real-Time Price · USD
0.806
-0.014 (-1.71%)
At close: Apr 18, 2024, 4:00 PM
0.818
+0.012 (1.49%)
After-hours: Apr 18, 2024, 7:31 PM EDT
Gossamer Bio Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Gossamer Bio stock have an average target of 8.60, with a low estimate of 4.00 and a high estimate of 15. The average target predicts an increase of 967.00% from the current stock price of 0.81.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Gossamer Bio stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 1 | 1 | 1 | 2 | 2 |
Buy | 3 | 1 | 1 | 1 | 2 | 3 |
Hold | 3 | 2 | 2 | 2 | 0 | 0 |
Sell | 1 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 10 | 4 | 4 | 4 | 4 | 5 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Wedbush | Wedbush | Buy Initiates $4 | Buy | Initiates | $4 | +396.28% | Apr 5, 2024 |
Piper Sandler | Piper Sandler | Buy Maintains $15 | Buy | Maintains | $15 | +1,761.04% | Mar 27, 2024 |
Goldman Sachs | Goldman Sachs | Strong Buy Maintains $9 → $8 | Strong Buy | Maintains | $9 → $8 | +892.56% | Mar 6, 2024 |
Wedbush | Wedbush | Buy Reiterates $6 | Buy | Reiterates | $6 | +644.42% | Mar 6, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +1,140.69% | Mar 6, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.77
from -1.18
EPS Next Year
-0.72
from -0.77
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | n/a | n/a | 41.0M | 321.3M | 417.9M |
Avg | n/a | n/a | 14.6M | 151.3M | 256.9M |
Low | n/a | n/a | n/a | 59.5M | 104.9M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | 2,102.8% | 176.2% |
Avg | - | - | - | 937.0% | 69.8% |
Low | - | - | - | 307.8% | -30.7% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -0.62 | -0.48 | 0.12 | 0.92 | 1.33 |
Avg | -0.77 | -0.72 | -0.48 | 0.09 | 0.46 |
Low | -0.92 | -0.98 | -0.90 | -0.41 | -0.12 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | 1,438.1% |
Avg | - | - | - | - | 435.3% |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.